Related references
Note: Only part of the references are listed.A Systems Analysis Identifies a Feedforward Inflammatory Circuit Leading to Lethal Influenza Infection
Marlene Brandes et al.
CELL (2013)
Influenza Mortality in the United States, 2009 Pandemic: Burden, Timing and Age Distribution
Ann M. Nguyen et al.
PLOS ONE (2013)
Rapid Generation of Human-Like Neutralizing Monoclonal Antibodies in Urgent Preparedness for Influenza Pandemics and Virulent Infectious Diseases
Weixu Meng et al.
PLOS ONE (2013)
Interferons as biomarkers and effectors: lessons learned from animal models
Cassandra M. Berry et al.
BIOMARKERS IN MEDICINE (2012)
The use of hyperimmune serum for severe influenza infections
Steven Rockman et al.
CRITICAL CARE MEDICINE (2012)
Passive immune neutralization strategies for prevention and control of influenza A infections
Jianqiang Ye et al.
IMMUNOTHERAPY (2012)
A Vero Cell-Derived Whole-Virus H5N1 Vaccine Effectively Induces Neuraminidase-Inhibiting Antibodies
Richard Fritz et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Structural and genetic basis for development of broadly neutralizing influenza antibodies
Daniel Lingwood et al.
NATURE (2012)
A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza
Nicasio Mancini et al.
ANTIVIRAL RESEARCH (2011)
Endothelial Cells Are Central Orchestrators of Cytokine Amplification during Influenza Virus Infection
John R. Teijaro et al.
CELL (2011)
Evaluation of Serological Diagnostic Methods for the 2009 Pandemic Influenza A (H1N1) Virus
Jesse Papenburg et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Production of Inactivated Influenza H5N1 Vaccines from MDCK Cells in Serum-Free Medium
Alan Yung-Chih Hu et al.
PLOS ONE (2011)
The Role of Neutrophils during Mild and Severe Influenza Virus Infections of Mice
Michelle D. Tate et al.
PLOS ONE (2011)
Airway immune homeostasis and implications for influenza-induced inflammation
Robert J. Snelgrove et al.
TRENDS IN IMMUNOLOGY (2011)
Type I Interferon Signaling Regulates Ly6Chi Monocytes and Neutrophils during Acute Viral Pneumonia in Mice
Sang-Uk Seo et al.
PLOS PATHOGENS (2011)
Intranasal Delivery of an IgA Monoclonal Antibody Effective against Sublethal H5N1 Influenza Virus Infection in Mice
Jianqiang Ye et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Host response to influenza virus: protection versus immunopathology
J. S. M. Peiris et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Prevention and Treatment of Influenza with Hyperimmune Bovine Colostrum Antibody
Wy Ching Ng et al.
PLOS ONE (2010)
Coated cross-species antibodies by mannosamine-biotin adduct confer protection against snake venom without eliciting humoral immune response
Tal Gefen et al.
VACCINE (2010)
Pre- and Postexposure Use of Human Monoclonal Antibody against H5N1 and H1N1 Influenza Virus in Mice: Viable Alternative to Oseltamivir
Wouter Koudstaal et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Early Control of H5N1 Influenza Virus Replication by the Type I Interferon Response in Mice
Kristy J. Szretter et al.
JOURNAL OF VIROLOGY (2009)
Universal epitopes of influenza virus hemagglutinins?
Taia T. Wang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Bovine and human-derived passive immunization could help slow a future avian influenza pandemic
Joseph Alisky
MEDICAL HYPOTHESES (2009)
Pandemic influenza - including a risk assessment of H5N1
J. K. Taubenberger et al.
REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES (2009)
Innate immune responses to influenza A H5N1: friend or foe?
Joseph Sriyal Malik Peiris et al.
TRENDS IN IMMUNOLOGY (2009)
Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein
Rongfang Wang et al.
ANTIVIRAL RESEARCH (2008)
Lack of cross-immune reactivity against influenza H5N1 from seasonal influenza vaccine in humans
Julian W. Tang et al.
JOURNAL OF MEDICAL VIROLOGY (2008)
Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic
Rafi Ahmed et al.
NATURE IMMUNOLOGY (2007)
Treatment with convalescent plasma for influenza A (H5N1) infection
Boping Zhou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Use of tetanus toxoid as a differentiating infected from vaccinated animals (DIVA) strategy for sero-surveillance of avian influenza virus vaccination in poultry
Cassandra M. James et al.
VACCINE (2007)
The interferons: 50 years after their discovery, there is much more to learn
Sidney Pestka
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein
Cassandra M. James et al.
VACCINE (2007)
Meta-analysis: Convalescent blood products for Spanish influenza pneumonia: A future H5N1 treatment?
Thomas C. Luke et al.
ANNALS OF INTERNAL MEDICINE (2006)
Influenza is now a preventable disease
J. S. Oxford et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
1918 influenza: the mother of all pandemics
JK Taubenberger et al.
EMERGING INFECTIOUS DISEASES (2006)
A review of vaccine research and development: Human acute respiratory infections
MP Girard et al.
VACCINE (2005)
Immunization against influenza A virus: Comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system
IC Brett et al.
VIROLOGY (2005)
Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice
AO Hovden et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2005)
Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice
A Takada et al.
VACCINE (2003)
Pulmonary administration of IgG loaded liposomes for passive immunoprophylaxy
C Dreffier et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2003)
Type I interferon gene therapy protects against cytomegalovirus-induced myocarditis
VS Cull et al.
IMMUNOLOGY (2002)